The Valley Desk

NCT05951959 · Interventional trial

A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma

Overall registry status Active not recruiting

Phase 2

Conditions Mantle Cell Lymphoma (MCL)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov